BRUE, or Brief Resolved Unexplained Events, is a medical condition that has been increasingly recognized in the medical community. It is a relatively new diagnosis, and it is still not fully understood. Because of its mysterious nature, it can be difficult for doctors to diagnose and treat. In this article, we will explore the mysterious case of BRUE, what is known about the condition, and how doctors can best diagnose and treat it. BRUE is a relatively new diagnosis, first described in 2016. It is a condition characterized by an event in which an infant stops breathing for at least 20 seconds and then resumes breathing on their own. It is often referred to as an “alarm event” because it is often preceded by an alarm-like sound or sensation. BRUE can occur at any age, but it is most common in infants. It is estimated that BRUE affects up to 1 in 10,000 infants in the United States each year. BRUE is a diagnosis of exclusion, meaning that other possible causes of the event must be ruled out before a diagnosis of BRUE can be made. Common causes of these events include sleep apnea, seizures, gastroesophageal reflux, and airway obstruction. In order for a diagnosis of BRUE to be made, all other possible causes must be ruled out.
The diagnosis of BRUE is based on the history of the event as reported by the parents or caretakers. It is important for doctors to ask questions about the event and to look for any signs or symptoms that may indicate a different cause. Doctors should also perform a physical examination of the infant to look for any signs of underlying illness or injury. In addition to the history and physical examination, doctors may also order tests to help rule out other possible causes. These tests may include an electroencephalogram (EEG) to look for seizure activity, a chest X-ray to look for any abnormalities in the lungs, or a laryngoscopy to look for any blockage in the airway.
Once a diagnosis of BRUE has been made, the goal of treatment is to prevent future events. The most common treatment for BRUE is lifestyle modifications such as avoiding triggers that may cause the events, such as loud noises or sudden movements. Itis also important for parents to ensure that the infant is getting enough rest and is not being over-stimulated. In some cases, medications may also be prescribed to help prevent future events. Commonly used medications include anticonvulsants and sedatives. It is important to note that medications should only be used as a last resort and should be used with caution.
BRUE is a mysterious condition that can be difficult to diagnose and treat. It is important for doctors to take a thorough history and perform a physical examination of the infant in order to rule out other possible causes. Once a diagnosis of BRUE has been made, lifestyle modifications and, in some cases, medications can be used to help prevent future events. With the proper diagnosis and treatment, the prognosis for infants with BRUE is generally good.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation